United StatesHealthcare and life sciences2025 – ongoingErlanger Baroness Hospital
Sentri7 drug-diversion monitoring
Erlanger's drug-monitoring AI missed approximately 5 instances of missing drugs, a nursing-board order documented
Problem
Hospitals needed to detect theft of controlled medicines, including drugs left over after surgery.
Approach
Erlanger used Wolters Kluwer's Sentri7 AI monitoring software. A nursing-board consent order documented missed alerts during a nurse's fentanyl diversion in 2025. Colleagues noticed impairment before the hospital audited the dispensing records.
Results
Takeaway
The board described an initial learning phase; the supplier disputed that such a phase existed. The reporting did not establish that Erlanger withdrew the system.
Categories
- Industry
- Healthcare and life sciences
- Business function
- Production and quality
- Innovation type
- Process innovation
- AI technology
- Predictive analytics and ML
- Adoption
- Vendor solution
- Goal
- Quality and risk
- Evidence
- Regulator, audit or court
Sources
Source summaries
KFF investigated a Tennessee nursing-board order documenting missed Sentri7 alerts. It reported the hospital's audit findings and conflicting explanations for the failure; neither the hospital nor supplier explained the incident.
Full details are in the original sources.